Compare HWBK & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HWBK | STXS |
|---|---|---|
| Founded | 1865 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 228.8M | 201.6M |
| IPO Year | 1996 | 2004 |
| Metric | HWBK | STXS |
|---|---|---|
| Price | $32.62 | $1.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 3.1K | ★ 385.7K |
| Earning Date | 04-29-2026 | 03-09-2026 |
| Dividend Yield | ★ 2.58% | N/A |
| EPS Growth | ★ 31.42 | 16.67 |
| EPS | ★ 3.43 | N/A |
| Revenue | N/A | ★ $29,346,617.00 |
| Revenue This Year | N/A | $34.08 |
| Revenue Next Year | N/A | $35.18 |
| P/E Ratio | $9.50 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $25.50 | $1.54 |
| 52 Week High | $36.25 | $3.59 |
| Indicator | HWBK | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 41.87 | 30.17 |
| Support Level | $32.33 | N/A |
| Resistance Level | $33.71 | $2.52 |
| Average True Range (ATR) | 0.83 | 0.12 |
| MACD | -0.11 | -0.02 |
| Stochastic Oscillator | 6.64 | 7.44 |
Hawthorn Bancshares Inc is a financial holding company that, along with its subsidiary bank, provides commercial banking for small and mid-sized businesses, including equipment, operating, commercial real estate and SBA loans, and personal banking services such as real estate mortgage lending, installment and consumer loans, certificates of deposit, checking, savings and money market accounts. The company also provides trust services including estate planning, investment and asset management services, brokerage and cash management services. Its primary source of revenue is net interest income derived from lending and deposit taking activities, with much of its business in commercial, commercial real estate development and residential mortgage lending.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.